Case Study
AVEVA Enables Xcellerex to Achieve Significant Reductions in Overall Operating Costs and Accelerates Time to Market
AVEVA Enables Xcellerex to Achieve Significant Reductions in Overall Operating Costs and Accelerates Time to Market
Goals y Address the growing demands in the biomedical market space for more effective biopharmaceutical manufacturing processes y Develop a solution that would define a model for improving how biopharmaceuticals, vaccines and other therapeutics are developed, manufactured and commercialised Challenges y Integrating complex technology with ultra-high levels of functionality was considered the greatest challenge in creating a biomanufacturing platform that employs a single-use technology, controlled environment modules, process automation and electronic batch records AVEVA Solution y System Platform y InTouch HMI y Batch Management y Historian Results y Xcellerex’s FlexFactory enabled companies to achieve significant cost savings in several areas, including a capita